Adenoviral Gene Therapy Death Will Be Explored By NIH rDNA Committee

Safety and efficacy of adenoviral vectors for therapeutic application will be examined at the Dec. 9-10 meeting of the NIH Recombinant DNA Advisory Committee. The action follows the death of a teenager enrolled in a gene therapy trial at the University of Pennsylvania Medical Center.